Cargando…
Fluorescent contrast agents for tumor surgery
Cancer is a leading cause of cases of mortality worldwide. The most effective method to cure solid tumors is surgery. Every year, >50% of cancer patients receive surgery to remove solid tumors. Surgery may increase the cure rate of most solid tumors by 4–11 fold. Surgery has many challenges, incl...
Autores principales: | Xiao, Qi, Chen, Tianming, Chen, Shilin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122374/ https://www.ncbi.nlm.nih.gov/pubmed/30186374 http://dx.doi.org/10.3892/etm.2018.6401 |
Ejemplares similares
-
AND-gate contrast agents for enhanced fluorescence-guided surgery
por: Widen, John C., et al.
Publicado: (2020) -
Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy
por: Cai, Xiaoxia, et al.
Publicado: (2019) -
Preliminary safety and imaging efficacy of the near-infrared fluorescent contrast agent DA364 during fluorescence-guided surgery in dogs with spontaneous superficial tumors
por: Favril, Sophie, et al.
Publicado: (2020) -
Ultrasound Induced Fluorescence of Nanoscale Liposome Contrast Agents
por: Zhang, Qimei, et al.
Publicado: (2016) -
Gadolinium-doped fluorescent carbon quantum dots as MRI contrast agents and fluorescent probes
por: Molaei, Mohammad Jafar
Publicado: (2022)